First Cases Confirmed: Oropouche Virus Arrives in Venezuela

Venezuelan health authorities have officially reported the detection of the first five cases of the Oropouche virus (OROV) within the country. This declaration, made on March 16th, follows a period of heightened vigilance and active epidemiological surveillance. The government has yet to specify the precise locations where thes cases were identified.

Understanding the Oropouche Virus: Transmission and Global presence

The Oropouche virus is an arbovirus, primarily spread through the bite of Culicoides mosquitoes, commonly known as hehe. Transmission can also occur, albeit less frequently, via Culex mosquitoes. These vectors are prevalent in various regions across Latin America, where recurring outbreaks have been documented. The WHO reported over 11,634 confirmed cases in the Americas as of December 2024, including fatalities in Brazil. The virus has also been detected in Bolivia, Canada, the Cayman Islands, Colombia, Cuba, Ecuador, the United States, Guyana, Panama, and Peru.

A History of Oropouche: From Revelation to Recent Outbreaks

The Oropouche virus was initially isolated in Trinidad and Tobago in 1955. Important outbreaks occurred in Brazil in 1961 and 1980. While sporadic cases have been observed in Latin America, 2024 saw a resurgence, with cases reported across Central America, South America, and the Caribbean. The Pan American Health Organization (PAHO) issued an alert in August 2024 due to the escalating number of infections.

Expert Predictions: Potential Impact in Venezuela

Internist-infectologist Julio Castro has shared projections regarding the potential impact of Oropouche in Venezuela, drawing on data from PAHO. Based on these models, Castro estimates that Venezuela could see between 700 and 1,500 cases within a 20-week period, with a peak expected around May. The duration of the outbreak could range from five to thirty weeks.

One of the central elements to try to identify what is happening with this virus is to maintain epidemiological surveillance, identification and denunciation of cases to have a more accurate outlook than we have.

Julio Castro, Internist-Infectologist

Transmission Vectors: Culicoides vs. Culex Mosquitoes

The Oropouche virus is primarily transmitted by Culicoides mosquitoes (or hejenes) and, to a lesser extent, by Culex mosquitoes. Culicoides typically inhabit jungle or peri-domestic environments in non-urban areas, unlike the Aedes aegypti mosquito, which transmits dengue. Culex mosquitoes are more commonly found in urban settings and are known for their nighttime biting habits.

Symptoms and Diagnosis: Differentiating Oropouche from Other Arboviruses

The incubation period for Oropouche ranges from three to twelve days. Symptoms frequently enough mimic those of dengue, including sudden high fever, intense headache, muscle and joint pain, and skin rashes. Nausea and vomiting are frequently observed in Oropouche cases, distinguishing it from other arboviral infections. Alarm signs include persistent fever, altered consciousness, and seizures.

diagnosis requires specific laboratory testing,currently available at specialized institutions like the National Hygiene Institute. If symptoms are present and tests for other common viruses are negative, consulting a specialist is recommended.

Treatment and Potential Complications

Currently, there is no specific antiviral treatment or vaccine for the Oropouche virus. Treatment focuses on managing symptoms, similar to dengue management: rest, hydration, and medications for fever and pain. Monitoring for complications, such as hypotension and neurological manifestations, is crucial.

Unlike dengue, Oropouche does not typically decrease platelet counts but can affect white blood cell levels. While mortality is lower than dengue, vulnerable populations, including the elderly, children, and individuals with chronic diseases, require careful attention. PAHO warns that infection during pregnancy may lead to fetal death and congenital defects. Neurological complications, such as Guillain-Barré syndrome, and severe complications like aseptic meningitis, are less common but possible. relapses of symptoms can occur weeks after initial recovery in approximately 60% of cases.

Prevention Strategies: Protecting Yourself and Your Community

Preventative measures include vector control, using mosquito nets, applying insect repellent, and maintaining basic hygiene to eliminate mosquito breeding sites. Covering water storage containers and changing the water frequently is also recommended. The Ministry of Health has announced ongoing surveillance at ports, airports, and border crossings, along with monitoring individuals with febrile symptoms. Vector control brigades will be deployed to eliminate breeding sites through fumigation and the use of biocontrol agents.